Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 1/2 9Phase NA 7Phase 1 7Phase 3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Leukemia 17Lymphoma 14Lymphoma, Large B-Cell, Diffuse 12Multiple Myeloma 10Lymphoma, Follicular 10Leukemia, Myeloid, Acute 10Breast Neoplasms 10Lymphoma, Non-Hodgkin 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Lymphoma, Mantle-Cell 6Leukemia, Myelomonocytic, Acute 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, Monocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Myeloproliferative Disorders 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Testicular Neoplasms 4Myelodysplastic Syndromes 4Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Testicular Germ Cell Tumor 3Teratoma, Testicular 3Teratoma 3Seminoma 3

Interventions

Dexamethasone 20Melphalan 13Thalidomide 10Bortezomib 10Lenalidomide 8Cyclophosphamide 8Prednisone 6Filgrastim 6Doxorubicin 6Vincristine 5Epoetin Alfa 5pomalidomide 3Zoledronic Acid 3Peripheral Blood Stem Cell Transplantation 3Idarubicin 3carfilzomib 2Vorinostat 2Radiotherapy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Darbepoetin alfa 2Carmustine 2Calcium Dobesilate 2Busulfan 2valspodar 1sargramostim 1oblimersen 1liposomal doxorubicin 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Plasma Cell × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00028886 2013-09-17

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 3 Unknown
450 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00004165 2012-06-06

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Northwestern University

Phase 3 Completed
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00008229 2010-09-21

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Fred Hutchinson Cancer Center

Phase 3 Completed
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡